[
  {
    "startTime": 0.0,
    "endTime": 7.0,
    "text": "Translator: Joseph Geni Reviewer: Morton Bast"
  },
  {
    "startTime": 16.837,
    "endTime": 18.833,
    "text": "I'd like to share with you"
  },
  {
    "startTime": 18.833,
    "endTime": 22.668999999999997,
    "text": "the story of one of my patients called Celine."
  },
  {
    "startTime": 22.67,
    "endTime": 25.823,
    "text": "Celine is a housewife and lives in a rural district"
  },
  {
    "startTime": 25.823,
    "endTime": 28.895,
    "text": "of Cameroon in west Central Africa."
  },
  {
    "startTime": 28.895,
    "endTime": 32.582,
    "text": "Six years ago, at the time of her HIV diagnosis,"
  },
  {
    "startTime": 32.582,
    "endTime": 35.583,
    "text": "she was recruited to participate in the clinical trial"
  },
  {
    "startTime": 35.583,
    "endTime": 38.653999999999996,
    "text": "which was running in her health district at the time."
  },
  {
    "startTime": 38.654,
    "endTime": 42.358000000000004,
    "text": "When I first met Celine, a little over a year ago,"
  },
  {
    "startTime": 42.358,
    "endTime": 44.41,
    "text": "she had gone for 18 months"
  },
  {
    "startTime": 44.42,
    "endTime": 46.329,
    "text": "without any antiretroviral therapy,"
  },
  {
    "startTime": 46.329,
    "endTime": 49.660000000000004,
    "text": "and she was very ill."
  },
  {
    "startTime": 49.66,
    "endTime": 51.464,
    "text": "She told me that she stopped coming to the clinic"
  },
  {
    "startTime": 51.464,
    "endTime": 53.15,
    "text": "when the trial ended"
  },
  {
    "startTime": 53.15,
    "endTime": 55.726,
    "text": "because she had no money for the bus fare"
  },
  {
    "startTime": 55.726,
    "endTime": 59.454,
    "text": "and was too ill to walk the 35-kilometer distance."
  },
  {
    "startTime": 59.454,
    "endTime": 61.198,
    "text": "Now during the clinical trial,"
  },
  {
    "startTime": 61.198,
    "endTime": 65.583,
    "text": "she'd been given all her antiretroviral drugs free of charge,"
  },
  {
    "startTime": 65.583,
    "endTime": 67.614,
    "text": "and her transportation costs"
  },
  {
    "startTime": 67.614,
    "endTime": 70.221,
    "text": "had been covered by the research funds."
  },
  {
    "startTime": 70.221,
    "endTime": 73.575,
    "text": "All of these ended once the trial was completed,"
  },
  {
    "startTime": 73.575,
    "endTime": 76.56700000000001,
    "text": "leaving Celine with no alternatives."
  },
  {
    "startTime": 76.567,
    "endTime": 79.243,
    "text": "She was unable to tell me the names of the drugs"
  },
  {
    "startTime": 79.243,
    "endTime": 81.27,
    "text": "she'd received during the trial,"
  },
  {
    "startTime": 81.27,
    "endTime": 84.27,
    "text": "or even what the trial had been about."
  },
  {
    "startTime": 84.27,
    "endTime": 87.576,
    "text": "I didn't bother to ask her what the results of the trial were"
  },
  {
    "startTime": 87.576,
    "endTime": 91.982,
    "text": "because it seemed obvious to me that she would have no clue."
  },
  {
    "startTime": 91.983,
    "endTime": 94.25200000000001,
    "text": "Yet what puzzled me most"
  },
  {
    "startTime": 94.252,
    "endTime": 97.359,
    "text": "was Celine had given her informed consent"
  },
  {
    "startTime": 97.359,
    "endTime": 101.19,
    "text": "to be a part of this trial, yet she clearly did not understand"
  },
  {
    "startTime": 101.191,
    "endTime": 103.661,
    "text": "the implications of being a participant"
  },
  {
    "startTime": 103.661,
    "endTime": 108.7,
    "text": "or what would happen to her once the trial had been completed."
  },
  {
    "startTime": 108.7,
    "endTime": 111.464,
    "text": "Now, I have shared this story with you as an example"
  },
  {
    "startTime": 111.465,
    "endTime": 114.394,
    "text": "of what can happen to participants in the clinical trial"
  },
  {
    "startTime": 114.394,
    "endTime": 116.85300000000001,
    "text": "when it is poorly conducted."
  },
  {
    "startTime": 116.853,
    "endTime": 120.717,
    "text": "Maybe this particular trial yielded exciting results."
  },
  {
    "startTime": 120.718,
    "endTime": 124.40700000000001,
    "text": "Maybe it even got published in a high-profile scientific journal."
  },
  {
    "startTime": 124.407,
    "endTime": 127.214,
    "text": "Maybe it would inform clinicians around the world"
  },
  {
    "startTime": 127.214,
    "endTime": 132.749,
    "text": "on how to improve on the clinical management of HIV patients."
  },
  {
    "startTime": 132.749,
    "endTime": 135.535,
    "text": "But it would have done so at a price"
  },
  {
    "startTime": 135.535,
    "endTime": 138.482,
    "text": "to hundreds of patients who, like Celine,"
  },
  {
    "startTime": 138.482,
    "endTime": 140.726,
    "text": "were left to their own devices"
  },
  {
    "startTime": 140.726,
    "endTime": 143.797,
    "text": "once the research had been completed."
  },
  {
    "startTime": 143.797,
    "endTime": 147.135,
    "text": "I do not stand here today to suggest in any way"
  },
  {
    "startTime": 147.135,
    "endTime": 149.148,
    "text": "that conducting HIV clinical trials"
  },
  {
    "startTime": 149.148,
    "endTime": 151.363,
    "text": "in developing countries is bad."
  },
  {
    "startTime": 151.363,
    "endTime": 155.73,
    "text": "On the contrary, clinical trials are extremely useful tools,"
  },
  {
    "startTime": 155.73,
    "endTime": 158.28,
    "text": "and are much needed to address the burden"
  },
  {
    "startTime": 158.28,
    "endTime": 160.499,
    "text": "of disease in developing countries."
  },
  {
    "startTime": 160.499,
    "endTime": 163.358,
    "text": "However, the inequalities that exist between"
  },
  {
    "startTime": 163.358,
    "endTime": 167.6,
    "text": "richer countries and developing countries in terms of funding"
  },
  {
    "startTime": 167.6,
    "endTime": 170.21699999999998,
    "text": "pose a real risk for exploitation,"
  },
  {
    "startTime": 170.217,
    "endTime": 174.102,
    "text": "especially in the context of externally-funded research."
  },
  {
    "startTime": 174.102,
    "endTime": 176.708,
    "text": "Sadly enough, the fact remains that"
  },
  {
    "startTime": 176.708,
    "endTime": 180.692,
    "text": "a lot of the studies that are conducted in developing countries"
  },
  {
    "startTime": 180.692,
    "endTime": 183.268,
    "text": "could never be authorized in the richer countries"
  },
  {
    "startTime": 183.268,
    "endTime": 185.516,
    "text": "which fund the research."
  },
  {
    "startTime": 185.516,
    "endTime": 187.762,
    "text": "I'm sure you must be asking yourselves"
  },
  {
    "startTime": 187.763,
    "endTime": 189.679,
    "text": "what makes developing countries,"
  },
  {
    "startTime": 189.679,
    "endTime": 192.223,
    "text": "especially those in sub-Saharan Africa,"
  },
  {
    "startTime": 192.223,
    "endTime": 195.79000000000002,
    "text": "so attractive for these HIV clinical trials?"
  },
  {
    "startTime": 195.79,
    "endTime": 199.60999999999999,
    "text": "Well, in order for a clinical trial to generate"
  },
  {
    "startTime": 199.62,
    "endTime": 202.178,
    "text": "valid and widely applicable results,"
  },
  {
    "startTime": 202.178,
    "endTime": 206.178,
    "text": "they need to be conducted with large numbers of study participants"
  },
  {
    "startTime": 206.178,
    "endTime": 208.821,
    "text": "and preferably on a population"
  },
  {
    "startTime": 208.821,
    "endTime": 212.602,
    "text": "with a high incidence of new HIV infections."
  },
  {
    "startTime": 212.602,
    "endTime": 216.73000000000002,
    "text": "Sub-Saharan Africa largely fits this description,"
  },
  {
    "startTime": 216.73,
    "endTime": 219.27499999999998,
    "text": "with 22 million people living with HIV,"
  },
  {
    "startTime": 219.275,
    "endTime": 222.915,
    "text": "an estimated 70 percent of the 30 million people"
  },
  {
    "startTime": 222.915,
    "endTime": 225.396,
    "text": "who are infected worldwide."
  },
  {
    "startTime": 225.396,
    "endTime": 227.826,
    "text": "Also, research within the continent"
  },
  {
    "startTime": 227.826,
    "endTime": 231.938,
    "text": "is a lot easier to conduct due to widespread poverty,"
  },
  {
    "startTime": 231.938,
    "endTime": 235.789,
    "text": "endemic diseases and inadequate health care systems."
  },
  {
    "startTime": 235.789,
    "endTime": 238.577,
    "text": "A clinical trial that is considered to be"
  },
  {
    "startTime": 238.578,
    "endTime": 241.328,
    "text": "potentially beneficial to the population"
  },
  {
    "startTime": 241.328,
    "endTime": 243.635,
    "text": "is more likely to be authorized,"
  },
  {
    "startTime": 243.635,
    "endTime": 246.435,
    "text": "and in the absence of good health care systems,"
  },
  {
    "startTime": 246.435,
    "endTime": 249.389,
    "text": "almost any offer of medical assistance"
  },
  {
    "startTime": 249.389,
    "endTime": 252.30700000000002,
    "text": "is accepted as better than nothing."
  },
  {
    "startTime": 252.307,
    "endTime": 254.893,
    "text": "Even more problematic reasons include"
  },
  {
    "startTime": 254.893,
    "endTime": 257.18,
    "text": "lower risk of litigation,"
  },
  {
    "startTime": 257.18,
    "endTime": 259.647,
    "text": "less rigorous ethical reviews,"
  },
  {
    "startTime": 259.647,
    "endTime": 262.203,
    "text": "and populations that are willing to participate"
  },
  {
    "startTime": 262.203,
    "endTime": 266.866,
    "text": "in almost any study that hints at a cure."
  },
  {
    "startTime": 266.867,
    "endTime": 270.492,
    "text": "As funding for HIV research"
  },
  {
    "startTime": 270.492,
    "endTime": 272.748,
    "text": "increases in developing countries"
  },
  {
    "startTime": 272.748,
    "endTime": 276.755,
    "text": "and ethical review in richer countries become more strict,"
  },
  {
    "startTime": 276.755,
    "endTime": 278.84,
    "text": "you can see why this context becomes"
  },
  {
    "startTime": 278.84,
    "endTime": 281.4,
    "text": "very, very attractive."
  },
  {
    "startTime": 281.401,
    "endTime": 285.81,
    "text": "The high prevalence of HIV drives researchers"
  },
  {
    "startTime": 285.81,
    "endTime": 289.565,
    "text": "to conduct research that is sometimes scientifically acceptable"
  },
  {
    "startTime": 289.565,
    "endTime": 292.844,
    "text": "but on many levels ethically questionable."
  },
  {
    "startTime": 292.844,
    "endTime": 296.283,
    "text": "How then can we ensure that, in our search for the cure,"
  },
  {
    "startTime": 296.283,
    "endTime": 298.603,
    "text": "we do not take an unfair advantage"
  },
  {
    "startTime": 298.603,
    "endTime": 302.107,
    "text": "of those who are already most affected by the pandemic?"
  },
  {
    "startTime": 302.107,
    "endTime": 305.963,
    "text": "I invite you to consider four areas I think we can focus on"
  },
  {
    "startTime": 305.963,
    "endTime": 309.538,
    "text": "in order to improve the way in which things are done."
  },
  {
    "startTime": 309.538,
    "endTime": 312.365,
    "text": "The first of these is informed consent."
  },
  {
    "startTime": 312.365,
    "endTime": 314.733,
    "text": "Now, in order for a clinical trial to be"
  },
  {
    "startTime": 314.733,
    "endTime": 318.414,
    "text": "considered ethically acceptable,"
  },
  {
    "startTime": 318.414,
    "endTime": 321.238,
    "text": "participants must be given the relevant information"
  },
  {
    "startTime": 321.238,
    "endTime": 323.673,
    "text": "in a way in which they can understand,"
  },
  {
    "startTime": 323.673,
    "endTime": 327.89,
    "text": "and must freely consent to participate in the trial."
  },
  {
    "startTime": 327.89,
    "endTime": 330.568,
    "text": "This is especially important in developing countries,"
  },
  {
    "startTime": 330.568,
    "endTime": 333.469,
    "text": "where a lot of participants consent to research"
  },
  {
    "startTime": 333.47,
    "endTime": 336.158,
    "text": "because they believe it is the only way in which"
  },
  {
    "startTime": 336.158,
    "endTime": 339.728,
    "text": "they can receive medical care or other benefits."
  },
  {
    "startTime": 339.728,
    "endTime": 342.695,
    "text": "Consent procedures that are used in richer countries"
  },
  {
    "startTime": 342.695,
    "endTime": 345.497,
    "text": "are often inappropriate or ineffective"
  },
  {
    "startTime": 345.497,
    "endTime": 347.85,
    "text": "in a lot of developing countries."
  },
  {
    "startTime": 347.85,
    "endTime": 350.82300000000004,
    "text": "For example, it is counterintuitive to have"
  },
  {
    "startTime": 350.823,
    "endTime": 353.822,
    "text": "an illiterate study participant, like Celine,"
  },
  {
    "startTime": 353.822,
    "endTime": 357.149,
    "text": "sign a lengthy consent form that they are unable to read,"
  },
  {
    "startTime": 357.149,
    "endTime": 359.25600000000003,
    "text": "let alone understand."
  },
  {
    "startTime": 359.256,
    "endTime": 362.335,
    "text": "Local communities need to be more involved"
  },
  {
    "startTime": 362.336,
    "endTime": 365.60900000000004,
    "text": "in establishing the criteria for recruiting participants"
  },
  {
    "startTime": 365.609,
    "endTime": 370.31,
    "text": "in clinical trials, as well as the incentives for participation."
  },
  {
    "startTime": 370.31,
    "endTime": 372.126,
    "text": "The information in these trials"
  },
  {
    "startTime": 372.126,
    "endTime": 375.77,
    "text": "needs to be given to the potential participants"
  },
  {
    "startTime": 375.77,
    "endTime": 379.505,
    "text": "in linguistically and culturally acceptable formats."
  },
  {
    "startTime": 379.505,
    "endTime": 382.326,
    "text": "The second point I would like for you to consider"
  },
  {
    "startTime": 382.326,
    "endTime": 384.764,
    "text": "is the standard of care that is provided"
  },
  {
    "startTime": 384.764,
    "endTime": 387.71000000000004,
    "text": "to participants within any clinical trial."
  },
  {
    "startTime": 387.71,
    "endTime": 391.407,
    "text": "Now, this is subject to a lot of debate and controversy."
  },
  {
    "startTime": 391.407,
    "endTime": 394.388,
    "text": "Should the control group in the clinical trial"
  },
  {
    "startTime": 394.388,
    "endTime": 397.661,
    "text": "be given the best current treatment which is available"
  },
  {
    "startTime": 397.661,
    "endTime": 399.741,
    "text": "anywhere in the world?"
  },
  {
    "startTime": 399.741,
    "endTime": 402.709,
    "text": "Or should they be given an alternative standard of care,"
  },
  {
    "startTime": 402.709,
    "endTime": 405.597,
    "text": "such as the best current treatment available"
  },
  {
    "startTime": 405.597,
    "endTime": 408.909,
    "text": "in the country in which the research is being conducted?"
  },
  {
    "startTime": 408.909,
    "endTime": 412.248,
    "text": "Is it fair to evaluate a treatment regimen"
  },
  {
    "startTime": 412.249,
    "endTime": 415.32500000000005,
    "text": "which may not be affordable or accessible"
  },
  {
    "startTime": 415.325,
    "endTime": 419.295,
    "text": "to the study participants once the research has been completed?"
  },
  {
    "startTime": 419.295,
    "endTime": 423.36,
    "text": "Now, in a situation where the best current treatment"
  },
  {
    "startTime": 423.36,
    "endTime": 425.675,
    "text": "is inexpensive and simple to deliver,"
  },
  {
    "startTime": 425.675,
    "endTime": 427.70300000000003,
    "text": "the answer is straightforward."
  },
  {
    "startTime": 427.703,
    "endTime": 430.852,
    "text": "However, the best current treatment available"
  },
  {
    "startTime": 430.853,
    "endTime": 433.74,
    "text": "anywhere in the world is often very difficult"
  },
  {
    "startTime": 433.74,
    "endTime": 436.427,
    "text": "to provide in developing countries."
  },
  {
    "startTime": 436.427,
    "endTime": 439.97900000000004,
    "text": "It is important to assess the potential risks and benefits"
  },
  {
    "startTime": 439.979,
    "endTime": 442.756,
    "text": "of the standard of care which is to be provided"
  },
  {
    "startTime": 442.756,
    "endTime": 445.236,
    "text": "to participants in any clinical trial,"
  },
  {
    "startTime": 445.237,
    "endTime": 450.685,
    "text": "and establish one which is relevant for the context of the study"
  },
  {
    "startTime": 450.685,
    "endTime": 454.182,
    "text": "and most beneficial for the participants within the study."
  },
  {
    "startTime": 454.182,
    "endTime": 457.433,
    "text": "That brings us to the third point I want you think about:"
  },
  {
    "startTime": 457.433,
    "endTime": 460.284,
    "text": "the ethical review of research."
  },
  {
    "startTime": 460.284,
    "endTime": 464.82,
    "text": "An effective system for reviewing the ethical suitability"
  },
  {
    "startTime": 464.83,
    "endTime": 468.21099999999996,
    "text": "of clinical trials is primordial to safeguard participants"
  },
  {
    "startTime": 468.211,
    "endTime": 470.324,
    "text": "within any clinical trial."
  },
  {
    "startTime": 470.324,
    "endTime": 473.236,
    "text": "Unfortunately, this is often lacking"
  },
  {
    "startTime": 473.236,
    "endTime": 476.764,
    "text": "or inefficient in a lot of developing countries."
  },
  {
    "startTime": 476.764,
    "endTime": 481.127,
    "text": "Local governments need to set up effective systems"
  },
  {
    "startTime": 481.127,
    "endTime": 484.40000000000003,
    "text": "for reviewing the ethical issues around the clinical trials"
  },
  {
    "startTime": 484.4,
    "endTime": 487.921,
    "text": "which are authorized in different developing countries,"
  },
  {
    "startTime": 487.921,
    "endTime": 490.195,
    "text": "and they need to do this by setting up"
  },
  {
    "startTime": 490.195,
    "endTime": 492.705,
    "text": "ethical review committees that are independent"
  },
  {
    "startTime": 492.705,
    "endTime": 496.9,
    "text": "of the government and research sponsors."
  },
  {
    "startTime": 496.9,
    "endTime": 498.5,
    "text": "Public accountability needs to be promoted"
  },
  {
    "startTime": 498.5,
    "endTime": 501.733,
    "text": "through transparency and independent review"
  },
  {
    "startTime": 501.733,
    "endTime": 504.772,
    "text": "by nongovernmental and international organizations"
  },
  {
    "startTime": 504.772,
    "endTime": 506.343,
    "text": "as appropriate."
  },
  {
    "startTime": 506.343,
    "endTime": 509.853,
    "text": "The final point I would like for you to consider tonight"
  },
  {
    "startTime": 509.853,
    "endTime": 513.76,
    "text": "is what happens to participants in the clinical trial"
  },
  {
    "startTime": 513.76,
    "endTime": 515.851,
    "text": "once the research has been completed."
  },
  {
    "startTime": 515.851,
    "endTime": 519.325,
    "text": "I think it is absolutely wrong for research to begin"
  },
  {
    "startTime": 519.325,
    "endTime": 521.837,
    "text": "in the first place without a clear plan"
  },
  {
    "startTime": 521.837,
    "endTime": 523.915,
    "text": "for what would happen to the participants"
  },
  {
    "startTime": 523.916,
    "endTime": 526.3560000000001,
    "text": "once the trial has ended."
  },
  {
    "startTime": 526.356,
    "endTime": 531.484,
    "text": "Now, researchers need to make every effort to ensure that"
  },
  {
    "startTime": 531.484,
    "endTime": 534.4680000000001,
    "text": "an intervention that has been shown to be beneficial"
  },
  {
    "startTime": 534.468,
    "endTime": 536.199,
    "text": "during a clinical trial"
  },
  {
    "startTime": 536.2,
    "endTime": 539.812,
    "text": "is accessible to the participants of the trial"
  },
  {
    "startTime": 539.812,
    "endTime": 542.36,
    "text": "once the trial has been completed."
  },
  {
    "startTime": 542.36,
    "endTime": 545.884,
    "text": "In addition, they should be able to consider the possibility"
  },
  {
    "startTime": 545.884,
    "endTime": 549.485,
    "text": "of introducing and maintaining effective treatments"
  },
  {
    "startTime": 549.485,
    "endTime": 553.326,
    "text": "in the wider community once the trial ends."
  },
  {
    "startTime": 553.326,
    "endTime": 556.749,
    "text": "If, for any reason, they feel that this might not be possible,"
  },
  {
    "startTime": 556.749,
    "endTime": 559.716,
    "text": "then I think they should have to ethically justify"
  },
  {
    "startTime": 559.716,
    "endTime": 563.743,
    "text": "why the clinical trial should be conducted in the first place."
  },
  {
    "startTime": 563.743,
    "endTime": 566.59,
    "text": "Now, fortunately for Celine,"
  },
  {
    "startTime": 566.59,
    "endTime": 568.7330000000001,
    "text": "our meeting did not end in my office."
  },
  {
    "startTime": 568.734,
    "endTime": 573.1080000000001,
    "text": "I was able to get her enrolled into a free HIV treatment program"
  },
  {
    "startTime": 573.108,
    "endTime": 574.496,
    "text": "closer to her home,"
  },
  {
    "startTime": 574.496,
    "endTime": 578.27,
    "text": "and with a support group to help her cope."
  },
  {
    "startTime": 578.27,
    "endTime": 580.603,
    "text": "Her story has a positive ending,"
  },
  {
    "startTime": 580.604,
    "endTime": 584.307,
    "text": "but there are thousands of others in similar situations"
  },
  {
    "startTime": 584.307,
    "endTime": 586.604,
    "text": "who are much less fortunate."
  },
  {
    "startTime": 586.604,
    "endTime": 589.2800000000001,
    "text": "Although she may not know this,"
  },
  {
    "startTime": 589.28,
    "endTime": 592.893,
    "text": "my encounter with Celine has completely changed the way"
  },
  {
    "startTime": 592.893,
    "endTime": 597.164,
    "text": "in which I view HIV clinical trials in developing countries,"
  },
  {
    "startTime": 597.164,
    "endTime": 600.884,
    "text": "and made me even more determined to be part of the movement"
  },
  {
    "startTime": 600.884,
    "endTime": 603.741,
    "text": "to change the way in which things are done."
  },
  {
    "startTime": 603.741,
    "endTime": 606.109,
    "text": "I believe that every single person"
  },
  {
    "startTime": 606.109,
    "endTime": 610.484,
    "text": "listening to me tonight can be part of that change."
  },
  {
    "startTime": 610.484,
    "endTime": 613.8100000000001,
    "text": "If you are a researcher, I hold you"
  },
  {
    "startTime": 613.81,
    "endTime": 615.651,
    "text": "to a higher standard of moral conscience,"
  },
  {
    "startTime": 615.651,
    "endTime": 618.78,
    "text": "to remain ethical in your research,"
  },
  {
    "startTime": 618.78,
    "endTime": 621.5659999999999,
    "text": "and not compromise human welfare in your search for answers."
  },
  {
    "startTime": 621.566,
    "endTime": 625.244,
    "text": "If you work for a funding agency or pharmaceutical company,"
  },
  {
    "startTime": 625.244,
    "endTime": 628.274,
    "text": "I challenge you to hold your employers"
  },
  {
    "startTime": 628.274,
    "endTime": 631.449,
    "text": "to fund research that is ethically sound."
  },
  {
    "startTime": 631.449,
    "endTime": 634.635,
    "text": "If you come from a developing country like myself,"
  },
  {
    "startTime": 634.635,
    "endTime": 637.707,
    "text": "I urge you to hold your government"
  },
  {
    "startTime": 637.707,
    "endTime": 640.323,
    "text": "to a more thorough review of the clinical trials"
  },
  {
    "startTime": 640.323,
    "endTime": 643.236,
    "text": "which are authorized in your country."
  },
  {
    "startTime": 643.236,
    "endTime": 646.904,
    "text": "Yes, there is a need for us to find a cure for HIV,"
  },
  {
    "startTime": 646.904,
    "endTime": 649.556,
    "text": "to find an effective vaccine for malaria,"
  },
  {
    "startTime": 649.556,
    "endTime": 653.398,
    "text": "to find a diagnostic tool that works for T.B.,"
  },
  {
    "startTime": 653.398,
    "endTime": 656.9730000000001,
    "text": "but I believe that we owe it to those who willingly"
  },
  {
    "startTime": 656.973,
    "endTime": 661.27,
    "text": "and selflessly consent to participate in these clinical trials"
  },
  {
    "startTime": 661.28,
    "endTime": 663.254,
    "text": "to do this in a humane way."
  },
  {
    "startTime": 663.254,
    "endTime": 665.581,
    "text": "Thank you."
  }
]